Sun Pharmaceutical Industries Merger & Restructuring Worth ₹9.5 Cr
Sun Pharma incorporates a new treasury subsidiary in GIFT City, Gandhinagar. Initial equity subscription is approximately ₹9.50 Crore for group treasury operations.
- Value
- ₹9.50 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Sun Pharma incorporates a new treasury subsidiary in GIFT City, Gandhinagar. Initial equity subscription is approximately ₹9.50 Crore for group treasury operations.
Sun Pharma announced that Organon stockholders approved the proposed merger, moving the acquisition forward. The deal remains subject to remaining customary closing conditions.
Sun Pharmaceutical Industries Limited incorporated a new 100% subsidiary, Sun Pharma America, Inc., in the USA on April 23, 2026. The entity belongs to the pharmaceutical industry and was established for internal group structuring purposes through initial cash consideration.